Skip to content
Search

Latest Stories

'Closure of 237 LloydsPharmacy store means 1% of UK community pharmacy network removed at once'

A decision by Hallo Healthcare to close more than two hundreds pharmacies has consequences not just for patients, communities but for the entire sector, the Pharmacists Defence' Association (PDA) told Pharmacy Business.

The closure of 237 LloydsPharmacy stores  means ‘over 1 per cent of the entire UK community pharmacy branch network has been removed at once’, said Paul Day, Director, PDA Union. 


On Monday (12 June), a spokesperson from LloydsPharmacy confirmed to Pharmacy Business that ‘any of its remaining branches in Sainsbury’ will be closed by Tuesday (13 June). 

Although LloydsPharmacy has been committed throughout the process of closure to helping patients easily find a suitable alternative provision, the move has impacted nearby pharmacies. 

Day said: “The patients that previously utilised the branches in Sainsbury’s, still exist.  Hence, from the perspective of those who work within community pharmacies that workload will now be redistributed and already busy teams in some geographies may be asking where the extra resources and physical space required will be coming from for them to safely and effectively add that work to their existing volumes.”

There have already been hundreds of other permanent pharmacy closures and operating hour reductions implemented by other major chains over recent years. 

Therefore, the association has urged those in the NHS across the UK nations, that are responsible for ensuring that pharmaceutical needs are met, need to ensure that communities are being adequately served. 

Impact on employees

Day explained: “For the individual pharmacists and their team members at LloydsPharmacy, unless they have secured an alternative role at Lloyds Pharmacy by filling an existing vacancy they will soon be leaving.”

“Once any reasonable “close down” tasks in the closing branch are completed they may either be temporarily helping at a nearby LloydsPharmacy if there is one and that is reasonable, or be at home on what is known as “garden leave”, until their notice period expires. 

The length of any contractual notice period will vary depending on an individual’s length of service and it is technically only at the end of their final day of their notice that an employee is “redundant”.”

The Trade Union side of the PDA supports members to understand and exercise their rights at work and this includes resolving any dispute about what is a reasonable alternative compared to a person’s existing role and/or activities.  

He added: "For the population that were previously employed by Sainsbury’s and whose employment has continued in their role the PDA is also supporting their dispute with the company as to which redundancy terms they should be paid (the Sainsbury’s terms being enhanced beyond the statutory minimum redundancy that LloydsPharmacy currently say is all they will pay)."

With regards to how PDA is supporting its members who were employed at LloydsPharmacy's Sainbury's branches, Day said: "Things are moving fast at Lloyds, with many branch sales.  We’ve about 1,000 members at Lloyds, but of course if their branch is sold or closed they are no longer Lloyds’ employees. We are ensuing those individuals can talk with us to understand and exercise their rights at work.  So we’ve sent them some information and also many have contacted our support centre with specific queries.  Each individual’s case may be different."

Community Pharmacy England, Chief Executive Janet Morrison, said that these closures are 'deeply worrying' and one of the clearest signals yet of just how much community pharmacies are struggling to make ends meet.

"Pharmacies are being chronically underfunded, with funding for community pharmacies being cut by 30% over the past seven years in real terms: combined with escalating costs, this has led to more extreme pressures on pharmacies than ever before. We know that many are at breaking point and this needs to be remedied immediately to protect access to pharmacy services.

When any pharmacy closes the impact on patients and local communities can be devastating. Other pharmacies locally will be braced for even more pressures as they try to cope with the increased demand and extra patients – but in their current fragile state, some pharmacies may simply not be able to cope with this. Other local health services may also see an increase in demand for help. We urgently need a funding uplift for pharmacies before it is too late for even more patients.”

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less